Medically reviewed by Khadeja Haye, MD The human papillomavirus (HPV) vaccine is recommended for people ages 9 to 26. Most ...
HPV vaccines aim to prevent the development of HPV-related cancers by stopping the viral infection from taking hold in the ...
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
Nationally, the average uptake for boys is 78.6% and 83.2% for girls. The HPV vaccine was introduced for girls in 2008 to ...
India plans to roll out the HPV vaccine in the national immunization programme for school girls to protect them from cervical ...
A new study from Public Health Scotland shows that no cervical cancer cases have been detected in fully vaccinated women ...
Thousands of school dropout girls between 11 and 14 years, and anti-vaxxers who have been spreading rumours are the main challenges for the success of the upcoming vaccination drive scheduled to start ...